ビタミンとミネラルの世界市場：2025年～2032年

世界のビタミンとミネラルの市場規模は、2024年に226億8,000万米ドルに達し、2032年には345億9,000万米ドルに達するとみられ、予測期間の2025年～2032年のCAGRは5.42％と予測されています。

ビタミンとミネラルは、さまざまな形で身体の開発に必要とされます。十分な量のミネラル摂取は、気分を改善し、ストレスレベルを下げます。骨を丈夫にし、傷を癒し、免疫システムを高めます。また、食物をエネルギーに変え、細胞の損傷を癒す働きもあります。ビタミンやミネラルが不足すると免疫力が低下し、さまざまな障害を引き起こします。

美的目標を達成しようとする若者の健康意識の高まりと、バランスの取れた食生活の必要性に対する人々の理解が、ビタミンとミネラル補助食品市場の盛り上がりを後押ししています。世界の顧客の60%以上が毎日ビタミンを使用しており、約55%が健康的なライフスタイルを維持するためにサプリメントを摂取するよう説得されています。消費者の効能に対する自信と信念、そして消費能力の向上が、プレミアム・ブランドが2022年以降に拡大するさまざまなチャンスを生み出しています。

ビタミンの欠乏は身体に様々な病気を引き起こします。ビタミンCが不足すると壊血病になり、ビタミンAが不足すると夜盲症になります。体内の筋力低下や骨の不調の最も一般的な原因はビタミン不足です。言うまでもなく、オフィスで働く成人人口が多い現在、食事だけでは日々の栄養所要量をまかなうことはできません。同様に、消費者は生活の生産性を高めるために、ホリスティックなライフスタイルを採用するようになっています。

その結果、人々の栄養と予防ヘルスケアに対する意識の高まりが、ビタミンとミネラルのサプリメントに対する世界の需要を押し上げています。多忙なライフスタイルや調理中の栄養損失によるビタミン欠乏症の蔓延は、消費者をビタミンとミネラルサプリメントの利用へと誘うとみられています。

世界保健機関（WHO）は、微量栄養素の欠乏症が世界で20億件以上あると推定しています。栄養補助食品の使用量は、すべての年齢層で70％増加しています。また、ビタミンやミネラルのサプリメントは、妊婦や40歳以上の人に強く勧められています。シエラレオネ、レソト、アフガニスタン、ナイジェリアなど、栄養不良の割合が高い国々は、ビタミンとミネラル部門にとって潜在的な可能性を秘めているかもしれません。

世界のビタミンとミネラル市場における主な抑制要因の一つは、原料価格の変動とサプライチェーンの混乱です。ビタミンとミネラルの生産は、アスコルビン酸（ビタミンC）、トコフェロール（ビタミンE）、各種ミネラル塩などの主要原料に依存しており、これらの原料は中国、インド、その他のアジア諸国からの調達が多いです。

規制上の制限、貿易政策、地政学的緊張による原料の入手可能性の変動は、世界の供給に影響を与える可能性があります。例えば、2023年に中国は化学薬品製造に対する環境規制を強化し、ビタミンCとビタミンB群の製造コスト上昇を招いた。その結果、供給不足と価格高騰が発生し、世界中のサプリメントメーカーに影響を与えました。

当レポートでは、世界のビタミンとミネラル市場について調査し、市場の概要とともに、製品別、流通チャネル別、形態別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析

第5章 業界分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 持続可能な分析
• DMIオピニオン

第6章 製品別

• ビタミン
  • ビタミンA
  • ビタミンB
  • ビタミンC
  • マルチビタミン
  • その他
• ミネラル
  • 亜鉛
  • カルシウム
  • その他
• マルチビタミン/ミネラル（MVM）サプリメント

第7章 流通チャネル別

• 病院薬局
• 小売薬局
• オンライン販売
• その他

第8章 形態別

• カプセル
• タブレット
• 粉末
• チュアブル
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他
• 南米
  • ブラジル
  • アルゼンチン
  • その他
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市場ポジショニング/シェア分析
• 合併と買収の分析

第11章 企業プロファイル

• AMWAY
• Lonza Group
• BASF SE
• Koninklijke DSM NV
• Du Pont
• Pfizer Inc.
• Nutrilo GmbH
• AIE Pharmaceuticals
• ParkAcre Enterprises
• Aland（Jiangsu）Nutraceutical

第12章 付録

Global vitamins and minerals market reached US$ 22.68 billion in 2024 and is expected to reach US$ 34.59 billion by 2032, growing with a CAGR of 5.42% during the forecast period 2025-2032.

Vitamins and minerals are needed for the body's development in a variety of ways. Mineral intake in sufficient amounts can improve mood and reduce stress levels. They strengthen the bones, heal wounds and boost the immune system. They also convert food to energy and heal cellular damage. Vitamin and mineral deficiencies can weaken the immune system and lead to a variety of disorders.

The growing health consciousness among young people to accomplish aesthetic goals, as well as people's understanding of the necessity of a balanced diet, is driving the rise of the vitamins and mineral supplements market. More than 60% of customers globally use vitamins daily, with approximately 55% persuaded to ingest supplements to maintain a healthy lifestyle. Consumers' confidence and belief in the benefits, as well as improved spending capacity, have created various chances for premium brands to expand in 2022 and beyond.

Dynamic

Growing Health Awareness

Vitamin deficiency causes a variety of ailments in our body. Vitamin C shortage results in scurvy, while vitamin A deficiency causes night blindness. The most prevalent cause of muscle weakness and bone discomfort in the body is vitamin deficiency. Needless to say, with a big adult population working in offices nowadays, a diet alone cannot provide daily nutritional requirements. Similarly, consumers are adopting a holistic lifestyle to increase productivity in their lives.

As a result, people's increased awareness of human nutrition and preventative healthcare is driving up global demand for vitamins and mineral supplements. The prevalence of vitamin deficiencies due to a hectic lifestyle and loss of nutrition during food preparation is likely to tempt consumers to use vitamins and minerals supplements.

The World Health Organization (WHO) estimates that there are over two billion cases of micronutrient deficiency worldwide. Dietary supplement usage has increased by 70% across all age groups. Also, vitamins and mineral supplements are highly suggested for pregnant women and those over the age of 40. Countries with greater malnutrition rates, such as Sierra Leone, Lesotho, Afghanistan and Nigeria, may present a potential for the vitamins and minerals sector.

Supply Chain Constraints and Raw Material Price Volatility

One major restraint in the global vitamins and minerals market is the volatility in raw material prices and supply chain disruptions. The production of vitamins and minerals depends on key ingredients such as ascorbic acid (Vitamin C), tocopherols (Vitamin E) and various mineral salts, which are heavily sourced from China, India and other Asian countries.

Any fluctuations in raw material availability due to regulatory restrictions, trade policies or geopolitical tensions can impact global supply. For example, in 2023, China imposed stricter environmental regulations on chemical manufacturing, leading to higher production costs for Vitamin C and B-complex vitamins. This resulted in supply shortages and price surges, affecting supplement manufacturers worldwide.

Segment Analysis

The global vitamins and minerals market is segmented based on product, distribution channel, form and region.

Multivitamin Capsules in the global market are expected to drive the market.

In 2024, the multivitamin capsules accounted for the largest percentage of the global vitamins and minerals market. Of all the vitamins and minerals, multivitamins are the most commonly ingested. These multivitamin tablets greatly assist the working population in meeting their daily nutritional requirements because the vitamins and minerals in these capsules can successfully relieve stress and depression symptoms. For example, Vitamin B promotes the neurological system to produce stress-relieving chemicals. Consuming enough vitamins and minerals might help the brain function and affect mood. According to a National Institute of Mental Health report, approximately 40% of Americans over the age of 50 take multivitamins.

A recent study found that taking a multivitamin or multimineral supplement on a regular basis or everyday improves cognition in older people over a three-year period. If verified by future investigation, these findings could provide a simple and cost-effective technique to decrease age-related memory loss, according to the researchers.

According to studies published in June 2023 by Brigham and Women's Hospital and Harvard Medical School, a multivitamin experiment showed surprisingly substantial effects on memory as we age. According to the 3,500 participants in the COSMOS-Web Study, who were aged 60 and older, taking a daily multivitamin reduced cognitive aging by 3.1 years compared to those who took placebos. COSMOS's second cognitive experiment, the clinical research, revealed that multivitamins may aid in minimizing memory loss.

Geographical Penetration

Growing Health Consciousness in North America

North America is expected to be the dominant region in the global vitamins and minerals market. The first multivitamin (MV) dietary supplements and multivitamin/mineral (MVM) were created in the early 1940s. MVMs, for example, are popular supplements; it is estimated that one-third of individuals in the United States already take them and one-fourth of children and teenagers do too. In the United States in 2019, MVMs and MVs accounted for 38% of all vitamin and mineral supplement sales and 14% of all supplement purchases. In 2020, the United States sold around US$ 55.7 billion in dietary supplements, with 21.2 billion coming from goods containing vitamins, minerals, or both and 8.0 billion coming from MVMs and MVs.

Multivitamins greatly assist the working population in meeting their daily nutritional requirements since the vitamins and minerals in this multivitamin pill can successfully relieve stress and depression symptoms. For example, vitamin B encourages the neurological system to create stress-relieving chemicals. Consuming vitamins and minerals in a suitable and appropriate method increases brain function and has a favorable effect on mood.

According to a poll performed by the National Institute of Mental Health, 40% of Americans over the age of 50 take multivitamin tablets. North America's healthcare system is progressively emphasizing preventive treatment to decrease the stress on the system. Vitamins and supplements are considered preventive measures, matching with this approach and supporting their use.

Competitive Landscape

The major global players in the market include AMWAY, Lonza Group, BASF SE, Koninklijke DSM N.V., Du Pont, Pfizer Inc., Nutrilo GmbH, AIE Pharmaceuticals, ParkAcre Enterprises and Aland (Jiangsu) Nutraceutical.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than Product generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product
• 3.2. Snippet by Distribution Channel
• 3.3. Snippet by Form
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Growing Health Awareness
  • 4.1.2. Restraints
    • 4.1.2.1. Supply Chain Constraints and Raw Material Price Volatility
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Sustainable Analysis
• 5.6. DMI Opinion

6. By Product

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 6.1.2. Market Attractiveness Index, By Product
• 6.2. Vitamins*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.2.3. Vitamin A
  • 6.2.4. Vitamin B
  • 6.2.5. Vitamin C
  • 6.2.6. Multivitamin
  • 6.2.7. Others
• 6.3. Minerals
  • 6.3.1. Zinc
  • 6.3.2. Calcium
  • 6.3.3. Others
• 6.4. Multivitamin/mineral (MVM) supplements

7. By Distribution Channel

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 7.1.2. Market Attractiveness Index, By Distribution Channel
• 7.2. Hospital Pharmacy*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Retail Pharmacy
• 7.4. Online Sales
• 7.5. Others

8. By Form

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 8.1.2. Market Attractiveness Index, By Form
• 8.2. Capsules*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Tablets
• 8.4. Powder
• 8.5. Chewable
• 8.6. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. US
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. UK
    • 9.3.6.3. France
    • 9.3.6.4. Italy
    • 9.3.6.5. Spain
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. Australia
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. AMWAY*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Lonza Group
• 11.3. BASF SE
• 11.4. Koninklijke DSM N.V.
• 11.5. Du Pont
• 11.6. Pfizer Inc.
• 11.7. Nutrilo GmbH
• 11.8. AIE Pharmaceuticals
• 11.9. ParkAcre Enterprises
• 11.10. Aland (Jiangsu) Nutraceutical

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us